Whitehawk Therapeutics (WHWK) Non Operating Income: 2018-2025
Historic Non Operating Income for Whitehawk Therapeutics (WHWK) over the last 7 years, with Sep 2025 value amounting to $1.8 million.
- Whitehawk Therapeutics' Non Operating Income rose 107.61% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $92.8 million, marking a year-over-year increase of 1946.83%. This contributed to the annual value of $3.8 million for FY2024, which is 38.93% down from last year.
- Per Whitehawk Therapeutics' latest filing, its Non Operating Income stood at $1.8 million for Q3 2025, which was down 15.65% from $2.1 million recorded in Q2 2025.
- Whitehawk Therapeutics' 5-year Non Operating Income high stood at $88.2 million for Q1 2025, and its period low was -$1.4 million during Q1 2021.
- Over the past 3 years, Whitehawk Therapeutics' median Non Operating Income value was $1.5 million (recorded in 2023), while the average stood at $9.3 million.
- Per our database at Business Quant, Whitehawk Therapeutics' Non Operating Income slumped by 95.73% in 2022 and then skyrocketed by 7,114.55% in 2025.
- Over the past 5 years, Whitehawk Therapeutics' Non Operating Income (Quarterly) stood at -$45,000 in 2021, then spiked by 3,544.44% to $1.6 million in 2022, then declined by 6.77% to $1.4 million in 2023, then tumbled by 53.22% to $676,000 in 2024, then soared by 107.61% to $1.8 million in 2025.
- Its Non Operating Income was $1.8 million in Q3 2025, compared to $2.1 million in Q2 2025 and $88.2 million in Q1 2025.